Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients > 60 Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia—A FILO Study

Documenti analoghi

• Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3 ‐Mutated AML : A FILO ‐ DATAML ‐ PETHEMA Real‐World Study
  di: Gaspar Aspas Requena, et al.
  Pubblicazione: (2026)
• Pleural Infiltration Revealing Post‐Essential Thrombocythemia Acute Myeloid Leukaemia
  di: Clémentine Muron, et al.
  Pubblicazione: (2025)
• Venetoclax–Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC‐DATAML‐MSKCC Retrospective Study
  di: Cassandre Petit, et al.
  Pubblicazione: (2025)
• Cytogenetic Diversity of Variant Philadelphia Translocations in Chronic Myeloid Leukemia
  di: Ayse Gul Bayrak Tokac, et al.
  Pubblicazione: (2026)
• Impact of Cytogenetic Response to Therapy on Long‐Term Survival in Acute Myeloid Leukemia
  di: John Hanna, et al.
  Pubblicazione: (2025)